TYMSP2

Across TCGA pan-cancer cohorts, TYMSP2 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated TYMSP2 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher TYMSP2 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TYMSP2 expression acts as an unfavorable survival marker, although some lineages such as STAD and LGG show a favorable association.

UCS, ACC, and STAD are the cancer types where TYMSP2 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.294	0.726	<.001	108	view →
ACC	DFS	Tertile	All	0.041	0.675	<.001	90	view →
STAD	DFS	Tertile	IV	0.780	0.175	.004	36	view →
COAD	DFS	Tertile	All	0.206	0.699	<.001	36	view →
LUSC	OS	Tertile	II,III,IV	0.161	0.537	.037	27	view →
LIHC	OS	Tertile	All	0.514	0.696	.038	21	view →
LGG	OS	Tertile	All	0.964	0.871	.030	18	view →
PCPG	DFS	Tertile	All	0.086	0.845	.022	9	view →
KIRC	OS	Tertile	All	0.492	0.676	.041	3	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

TYMSP2–UCS (OS)

Open the UCS breakdown →